Scott K. has extensive experience in pharmacoepidemiology and risk assessment, currently serving as Senior Director at Pfizer since April 2020, leading the RWE Pharmacoepidemiology and Risk Contextualization Group. Scott oversees various studies involving machine learning, genetic epidemiology, and risk prediction across multiple therapeutic areas including infectious disease and oncology. Prior to Pfizer, Scott was the Lead Epidemiologist at the American Academy of Ophthalmology and held multiple positions at the National Cancer Institute and Georgetown University. Scott earned a Ph.D. in Epidemiology from The George Washington University and a Master's degree in Biostatistics/Epidemiology from Georgetown University.
This person is not in any teams
This person is not in any offices